Verbal memory after three months of intranasal vasopressin in healthy old humans.
In animals, evidence has been accumulated that vasopressin (VP) improves learning and memory. In humans, this effect was not consistently demonstrated, and attempts to restore age-related memory deficits by VP also remained inconsistent. Assuming that in old subjects a beneficial effect on memory occurs only after prolonged treatment with VP, we conducted a study in 26 healthy elderly persons receiving 40 IU of VP for three months through the intranasal route. The trial was randomized, placebo-controlled and held double-blind. Memory was assessed by the Auditory Verbal Learning Test (AVLT) requiring the subject to learn repeatedly presented lists of 15 words. Results demonstrated no general effect of long-term treatment with VP on memory in aged humans. However, recall of an interfering word list was improved, indicating a diminished proactive interference by the peptide. Additionally, VP influenced recall depending on the serial position of an item: it improved the primacy effect (i.e. recall of the first words of a list) and impaired the recency effect. This result may indicate an improved semantic encoding (i.e. a primary effect on processes of attention) after long-term administration of VP.
Perras
B
B
Department of Clinical Neuroendocrinology, University of Lübeck, Germany.
Droste
C
C
Born
J
J
Fehm
H L
HL
Pietrowsky
R
R
D000281:Administration, Intranasal; D000368:Aged; D000369:Aged, 80 and over; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory / Q000502:physiology*; D008569:Memory Disorders / Q000523:psychology; D011939:Mental Recall / Q000187:drug effects; D009483:Neuropsychological Tests; D014667:Vasopressins / Q000008:administration & dosage / Q000494:pharmacology*; D014706:Verbal Learning / Q000187:drug effects
D014667:Vasopressins